“Among young adult aged survivors of childhood cancer, dexrazoxane was associated with a cardioprotective effect nearly 20 years after initial anthracycline exposure,” Eric J. Chow, MD, MPH, and colleagues.
“Among young adult aged survivors of childhood cancer, dexrazoxane was associated with a cardioprotective effect nearly 20 years after initial anthracycline exposure,” Eric J. Chow, MD, MPH, and colleagues.
Join the coalition